Key result
This article reviews current endovascular and epicardial catheter-based left atrial appendage occlusion devices and the clinical data supporting their use for stroke prevention in atrial fibrillation.
Why the study?
Does endovascular and epicardial catheter-based left atrial appendage (LAA) occlusion devices prevent stroke in patients with atrial fibrillation?
Population
Patients with atrial fibrillation
Comparison
Endovascular and epicardial catheter-based left… vs Systemic anticoagulation
Design
Review
Authors
Loading...
LAA occlusion devices may serve as anticoagulation alternatives in select AF patients; leaves open need for additional randomized efficacy data.
Does endovascular and epicardial catheter-based left atrial appendage (LAA) occlusion devices prevent stroke in patients with atrial fibrillation?
Catheter-based left atrial appendage occlusion devices are reviewed as an emerging alternative to systemic anticoagulation for stroke prevention in patients with atrial fibrillation.
Kapur et al. (2011) conducted a review in Atrial fibrillation. Left atrial appendage (LAA) occlusion devices was evaluated. This article reviews current endovascular and epicardial catheter-based left atrial appendage occlusion devices and the clinical data supporting their use for stroke prevention in atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: